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In a  previous paper  (1)  we described the appearance of a  soluble circulating 
antibody-antigen complex in rabbits after single intravenous injections of large 
doses  of bovine  plasma  albumin  or  bovine  plasma  gamma  globulin,  or  after 
intramuscular  injections of these agents  with Freund's adjuvants.  The soluble 
complex was demonstrated in the serum by brief exposure to alkali in the cold 
followed by neutralization  and  incubation.  Upon  this  treatment  precipitates 
separated  spontaneously in some immune sera but not in normal serum. 1 The 
specificity of the precipitates  was demonstrated  by resuspension  in  an  excess 
of specific antigen;  the precipitates  were soluble  in specific antigen  but not in 
non-specific  protein  (Fig.  1). 
It was puzzling that large amounts of antigen and antibody could coexist in 
circulation without precipitating.  The solubility of the antibody-antigen  com- 
plex did not depend upon the solubilizing effect of excess antigen on precipitating 
antibody,  since  the complex was found in serum obtained early in immuniza- 
tion,  while excess antigen prevailed in circulation,  as well as in later phases  of 
immunization  when free antigen  had  disappeared  from circulation  and excess 
of free antibody was present or absent. The failure of the complex to precipitate 
in circulation  appeared  to result,  therefore,  from the nature  of either  its anti- 
body or its antigen component. The present paper will show that the antibody 
of  the  complex  is  non-precipitating  antibody. 
The  procedure  used  for  demonstration  of  non-precipitating  antibody  was 
suggested by the following consideration: If soluble antibody-antigen complex 
is derived from a combination of antigen and non-precipitating antibody in vivo 
some sera may be found to possess non-precipitating antibody in excess of that 
* Supported  by a grant from  Ciba  Pharmaceutical  Products,  Inc. Presented  in  part at 
the Ciba Symposium of Recent Advances in Hypersensitivity  at the llth Annual  Meeting of 
the American Academy of Allergy, New York, February 7-9, 1955, and  at  the 39th  Annual 
Meeting  of the American Association of Immunologists,  San Francisco, April  10-15, 1955. 
1  For illustration see Fig. 1 in reference 22. 
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necessary to bind all the antigen. Such uncombined antibody would not precipi- 
tate upon addition of antigen to the original serum.  Since the alkali treatment 
converts  non-precipitating  antibody-antigen  complex  to  a  precipitating  form 
there may be a  likelihood that it would  also convert non-precipitating uncom- 
bined antibody  to  precipitating  uncombined  antibody.  The  uncombined  non- 
precipitating  antibody  might,  therefore,  precipitate  if  antigen  were  added  to 
the  treated  serum. 
Fro.  1.  Test  for specificity.  Rabbit blood was obtained after immunization  with CBPA. 
The serum was treated with alkali and antibody-antigen complex allowed to separate  for one 
day at I°C. It was then resuspended and mixed with an equal volume of 0.85 per cent sodium 
chloride solution containing merthiolate 1 : 10,000 and with a  1:6.7 solution of BP'yG, CBPA, 
and powdered BPA respectively. 
Materials and Methods 
Antisera.--Flemish Cross giant male rabbits 6 months old were immunized by biweekly or 
triweekly intravenous injections of 0.1 gm./kg, of crystalline bovine plasma albumin (CBPA)  2 
or bovine plasma gamma globulin (BP"yG) ~ or by a  single intramuscular injection of 80 rag. 
of these agents or of 80 mg. of powdered bovine plasma albumin with Freund's complete ad- 
juvants (2, 3). Blood was obtained in 60 ml. amounts by ear artery puncture, the serum sepa- 
rated under aseptic conditions and merthiolate  ® added  to a  concentration of l:10,000.  The 
sera from rabbits receiving intravenous injections of antigen were obtained 2 weeks after each 
injection, quick frozen at about -60°C. and stored at about --23°C.  Immediately before use 
these sera were thawed at 37  °, pooled, and kept at I°C. The sera from rabbits immunized with 
Freund's adjuvants were obtained in weekly  or biweekly bleedings of 60  ml.  each between 
the 28th and  the 322nd  day  after immunization.  Following addition  of  merthiolate  ® they 
2 CBPA, crystalline bovine plasma Mbumin. 
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were stored at I°C. under aseptic conditions. At irregular intervals the sera were pooled and 
either lyophilized or Seitz-filtered. 
Antig~s.--Crystalline bovine plasma albumin (CBPA) and bovine plasma gamma globulin 
(BPTG) were obtained from Armour and Company,  Chicago.  Crystalline egg  albumin was 
prepared by the method of Keckwick and  Carman (4),  quick  frozen at -60°C.,  and stored 
at -23°C.  All  test antigens were  diluted  in  0.16  N  sodium  chloride  solution  containing 
merthiolate  @ 1:10,000.  Their protein  contents were  determined  with  the  Folin-Ciocalteu 
reagent by the method of Heidelberger and McPherson (5) and the nitrogen equivalent of 
the optical densities encountered at various  concentrations was  established by comparison 
with nesslerization (6). 
Treatment of Serum with Alkali.--As  described previously (1)  sodium hydroxide solution 
was added to the serum at I°C.  until the pH read 12.7.  (This corresponds to a  pH of 12.6 
if the combined error of temperature adjustment and sodium ion concentration is taken into 
account. Much less alkali is needed than at room temperature and it is not implied that a 
true pH of 12.6 is attained. For details of pH adjustment  see reference 7). Mter 6 minutes 
of exposure to alkali the serum was neutralized to the original pH. The serum was not incu- 
bated as described previously at 56°C. for 30 minutes before alkali treatment, since heat in- 
activation had no discernible effect on the determination of circulating antibody-antigen com- 
plex by precipitation and since no complement fixation tests were done in the present work. 
gstlm~  of Antlbody-Anggm Complex.--4 ml. triplicate portions of alkali-treated  sera 
or diluted untreated controls were left at 1  ° for 11 days.  (Incubation at 37°C. for 2 hours as 
previously reported (1) was omitted). The precipitates that formed were centrifuged at 1000 
g 1°C. for20 minutes and washed 3 times with 6.0 nil. portions of 0.16 N sodium chloride solu- 
tion at  I°C.  Their protein contents were determined  by the method  of Heidelberger and 
McPherson (5). 
Reaction of Antibody and Antigen in Alkali-Trea~  Sera.--4 ml. portions of supernates 
from the tubes with alkali-treated sera and from untreated controls were added in duplicates 
or triplicates to 1.0 mi. portions of various concentrations of antigen in 0.16 s  sodium chloride 
solution containing merthiolate 1:10,000.  The tubes were left at  1°C.  for 11  days and any 
precipitates were centrifuged, washed, and estimated as described for antibody-antigen com- 
plex. 
Radioiodina~ion of  Antigen.--Antigen was labelled with 1  lal by the method of  Gilmore 
and  coworkers  (8)  with  the  following  modifications:  For  the  iodination  of  each  gram 
of protein only 4.34 mg. of carrier potassium iodide and 0.2 gln. ammonium persulfate were 
used. The ammonium persulfate solution was brought to pH 7.6 with sodium hydroxide  as 
suggested by Radin  (9). 94 per cent of the labelled BPTG and 100 per cent  of the labelled 
CBPA were precipitable by specific antiserum. 
Estimation of Antigen.--In some experiments free antigen was determined by the method 
of Heidelberger and Kendall (I0) which involves the addition of an excess of calibrated anti- 
serum to an unknown amount of antigen. Determinations were made in duplicates or tripli- 
eates on the supernates remaining after  addition  of  antigen to alkali-treated or untreated 
sera. In other experiments Ilal-labelied antigen was estimated in a  well scintillation counter 
on 2  ml. samples of washed duplicate antibody-antigen precipitates dissolved in 2.2 ml. of 
5 ~ sodium hydroxide. 
Agar Diffusion Studies.--Serum agar tubes were set up by the method of Oudin (11) as 
described by Vaughan and Kabat (12). The tubes of experiments with CBPA as antigen were 
kept at I°C. and those of experiments with BPTG at 23°C. 
EXPEI~T~.NTS  AND  RESULTS 
Experiment 1. Precipitates  Obtained from Mixtures o¢ Antigen and Antiserum 
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from rabbits injected intravenously  with CBPA was mixed with varying quanti- 
ties of antigen and the precipitates that formed were removed. Treatment of 
the supernates with alkali resulted in conversion of non-precipitating to pre- 
cipitating antibody-antigen  complex. It will be seen that more antibody-antigen 
complex was precipitated from serum samples mixed with antigen than from 
controls mixed with saline. 
Serum was obtained on day 49 from a  rabbit that had received intravenous injections of 
0.1 mg./kg, of CBPA on days 0, 14, and 35. The serum was divided into 4 portions. An equal 
Precipitates Formed 
0 
5 
72 
720 
TABLE  I 
in Alkali-Treated Supernates Obtained from Mixtures of Anti-CBPA and 
Varying A mounts of Antigen 
(s) 
0 
0 
(5)  (7) 
=o  ,~ 
.... 
211" 
306  95 
404  193 
559  348 
(2)  (3)  (4) 
~  ~  ~-~. 
0  45 
49  Excess  4 
antibody 
42  Excess  No band 
antigen 
8  Excess  No band 
antigen 
(8)  (9) 
~_~.~ 
165 
Excess anti-  18 
body 
Excess anti- 
body and 
antigen  32 
Excess anti- 
gen  No band 
* This precipitate may contain some complement-like material.  The other precipitates 
obtained after alkali treatment are presumably free of complement since they are derived 
from serum portions pretreated with antigen. 
5 Each number represents one band and indicates the highest dilution of serum before 
admixture with agar at which the band was visible. 
volume of merthiolated saline was added to the first portion and equal volumes of CBPA 
solution containing 5, 72, and 720/zg. of antigen nitrogen per ml. were added to the succeed- 
ing portions. All mixtures were incubated and stored and precipitates determined as previously 
described. Each of the supernates was divided into 2 portions. One of each of these 2 portions 
was treated with alkali and made up to 4 volumes with respect to the original serum. The other 
was not treated but simply diluted to 4 volumes. Any precipitates that formed upon storage 
of 4 ml. samples of these treated and untreated portions were separated by centrifugation and 
a  new set of supernates was obtained. The protein cOntent of the washed precipitates was 
estimated (Table I, columns 5 and 6). The new superuates were tested for the presence of re- 
maining antigen and antibody  (columns 3 and 8) and for the  capacity  of forming  bands of 
precipitation in agar tubes upon diffusion of 4 per cent CBPA by the Oudin technique (columns 
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Table I, column 2, gives the amounts of precipitate obtained upon addition 
of varying quantities of antigen to the serum. Tests on the resulting superuates 
(columns 3 and 4) show that 5 #g. antigen nitrogen per ml. of serum left pre- 
cipitating antibody ill solution, while 72 and 720 #g. antigen nitrogen per ml. 
left antigen but no precipitating antibody. Simple dilution and storage of the 
supernates  failed  to  produce  additional  precipitation  (column  5).  However, 
when these supernates were treated with alkali large amounts of precipitate 
were obtained (column 6) indicating the presence of antibody-antigen complex. 
The precipitate from the treated supernate of the serum sample to which no 
antigen  was added reflects  the contents of antibody-antigen complex  of  the 
original  serum. Addition of antigen to the serum followed by removal of pre- 
cipitating  antibody  increased  the  amount  of  non-precipitating  antibody- 
antigen complex disclosed  by precipitation after alkali treatment. 
Gel diffusion analysis suggested that the antibody disclosed in the untreated 
or alkali-treated serum reacted with a single component of the antigen (columns 
4 and 9).  After addition of various quantities of antigen and removal of the 
ensuing precipitates, the untreated supernates contained either excess of antigen 
or excess of antibody but not both  (column 3). Thus,  following  addition of 
72 #g. CBPA nitrogen per ml. to the untreated serum,  the supernate contained 
excess of antigen  only. However, when this supernate  was treated by alkali 
and  antibody-antigen  complex allowed to  separate,  the  new supernate  con- 
tained both, excess of antigen as well as excess of material  giving  a  band of 
precipitation  upon gel diffusion  (column 8).  Inhibition  by antigen  excess of 
precipitation  of the material  disclosed  by alkali  treatment was not apparent 
in the present experiment. However, in other experiments such inhibition was 
obtained with larger  amounts of antigen  (3  to  25 rag.  nitrogen per  ml. un- 
diluted serum). 
There may be two reasons for the increase  of precipitation in alkali-treated 
serum samples depleted to varying degrees  of precipitating  antibody by the 
addition of antigen  as compared to samples to which no antigen was added. 
Either  part  of the antigen  may have aggregated  with  the antibody-antigen 
complex existing in  the serum or antigen  may have caused precipitation  of 
another soluble serum factor after alkali treatment.  To clarify this point the 
following experiment was performed. 
Experiment 2. Conversion of a Non-Precipitating Serum Factor to a Precipitin- 
Like Material  in Serum  Depleted of Precipitating  Antibody  and  of Antibody- 
Antigen Complex.--The  procedure is illustrated  diagrammatically  in  Fig.  2. 
Serum is depleted of precipitating antibody by addition of a sufficient amount 
of antigen (a single addition of antigen in equivalence or a series of additions 
of antigen  in  antibody excess  is satisfactory).  The  precipitate  composed of 
precipitating antibody and antigen is removed (Fig. 2, tube 2). The supemate, 528  STUDIES  ON  NON-PRECIPITATING ANTIBODY. I 
now devoid of precipitating antibody (tube 3), is treated by alkali. A precipitate 
composed of antibody-antigen complex forms (tube 4) and is removed. When 
specific antigen is added to the supernate (tube 5) a precipitate forms (tube 6). 
This is a specific precipitate since none forms upon addition of a non-specific 
protein,  as illustrated by tube  7.  Serum depleted of precipitating antibody 
(tube 8),  which is  not  treated by alkali,  forms no spontaneous precipitate 
3 
depleted 
$gPurn 
-t" e,  ntic~an  ,._ ~  spn: serum  deplet:ed 
•  of precipi~:atin~  Ab 
I  ecluivalenca2  "  pj~::.: ppt.Ab  and h~ 
"  '- 
~'~  6 I!111~  + antigen 
p,H 12.e, I°C~,  6ml  ,,.~norh  s   'oN 
pp~: Ab-A,~  "  "~elg".-.~ 
complex  ?  no pF  t. 
depleted  no ppt.  spn. 
5~Pum 
4" antigen  ) 
II  no ppt. 
FIG. 2.  Schematic representation of  estimation of non-precipitating antibody in serum 
following  depletion of precipitating antibody, alkali treatment, and removal of antibody- 
antigen complex. 
(tube  9).  Additional treatment  of  this  serum  with  specific  antigen  does not 
produce a  precipitate  either  (tube 11).  The following is a  detailed description 
of  such  an  experiment. 
A pool of sera from rabbits which had received  2 biweekly intravenous injections of 0.I 
mg./kg, of CBPA was obtained 2 weeks after the second injection. Two derivatives from this 
pool were used. One, serum A, was depleted of precipitating antibody only, and the other, 
serum B, was depleted of precipitating as well  as  coprecipitating antibody ("monovalent" 
antibody of Heidelberger (13)). Non-depleted serum was also used in some phases of the ex- 
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Serum A was prepared by 2 additions of 1.4/~g.  CBPA per ml. (first admixture at 37"C. 
for 2 hours, followed by centrlfugation'at 1000 g at I°C. for 20 minutes, second absorption at 
37*  for 2  hours,  followed  by  storage  at  I°C.  for  11  days  and  centrifugation  at  1000  g 
at I°C. for 40 minutes). After the two treatments with antigen the serum fated  to form pre- 
cipitates with varying quantities of antigen in a  qualitative test involving incubation for 2 
hours at 37 ° and i  day at I°C. 
Serum B was prepared like serum A but in addition was depleted of coprecipitating anti- 
body with a potent anti-BPA rabbit serum produced with Fretmd's adjuvants and an amount 
of antigen known  to precipitate with this antiserum in slight antigen excess.  The protocol 
TABLE II 
Estimation  of  Copredpitating  Antibody  in  Anti-CBPA  Depltded  of  Pre~ipitaAing  Antibody 
Precipitating rabbit anti-BPA pool, mt  ......... 
Normal rabbit serum, ml  ..................... 
Merthiolated saline, ml  ...................... 
Rabbit  anti-CBPA  depleted  of  precipitating 
antibody, ml. (dilution 1:1.2) ............... 
CBPA, 18 ~g. N/ml., m/  ...................... 
Pooled supernate from column 2, m/  ............ 
Nitrogen precipitated, #g  ...................... 
Antigen in supernate, I~g  ...................... 
Coprecipitating antibody, #g  ................... 
I_ 
0.i 
1.0 
0.2 
1.0 
105" 
311 
0.1  0.1 
1.2 
1.0  1.0 
--  2.3 
1265  102§ 
011  Excess  anti- 
gen¶ 
18 
All tubes were incubated at 37  ° for 2 hours and  left at 1  ° for 11 days. Sera were separated 
by centrifugation at 1000 g 1  ° for 20 minutes. Column 3 was set up in order to show whether 
the removal of coprecipitating antibody in column 2 was complete. 
* Average of septet determinations. 
Average of quadruplicate determinations. 
§ Average of triplicate determinations. 
II Estimated with ealibmted antiserum. 
¶ Qualitative estimation only. 
for this procedure is given in Table II. Each milliliter of serum depleted of precipitating anti- 
body contained 18 #g. of coprecipitating antibody nitrogen. 
Non-depleted serum, sera A and B were divided into two portions each. One of each was 
treated with alkali to precipitate antibody-antigen complex and made up with merthiolated 
saline to 4 volumes with respect to the original non-depleted serum. The other of each portion 
(control) was merely diluted to 4 volumes with merthiotated saline. The resulting six serum 
preparations were kept at I°C. for 11 days and centrifuged at 1000 g at I°C. for 40 minutes. 
This removed the antibody-antigen complex, disclosed  in the three treated  serum prepara- 
tions. Its quantity was estimated from the washed precipitates obtained from aliquot tripli- 
cate samples of 4 ml. each of the six serum preparations (Table III). 
The number of participating antibody-antigen systems remaining in the supemates of the 
six serum preparations was determined from the number of bands formed upon diffusion of 
a 4 per cent solution of CBPA into mixtures of the serum preparations with agar (Table IV). 
The supernates of the following 4 of the 6 serum preparations described were used to es- 530  STUDIES  ON  NON-PRECIPITATING  ANTIBODY.  I 
tablish the amount of material precipitating with antigen from alkali-trcated serum after re- 
moval of precipitating antibody: The superuates obtained after allowing antibody-antigen 
complex to separate from alkali-treated serum A and B and, as controls, the superuates from 
the diluted untreated portions of serum A and B. Four ml. duplicate samples of the supernates 
were added to 1.0 ml. volumes of varying quantities of CBPA or merthiolated saline or crystal- 
TABLE  III 
Antgbody-Antigen Complex in Non-Depleted and Depleted AnlI-CBPA Serum 
Non-depleted serum ............................................... 
Serum depleted of precipitating antibody (serum A) ................... 
Serum depleted of precipitating and coprecipitating antibody (serum B).. 
/~g. antibody-antlgen 
complex N precipi- 
tated/ml, undiluted 
seruln 
120" 
169 
253~ 
* This precipitate may contain some complement-like material.  The other precipitates 
are presumably free of complement since they are derived from serum pretreated with antigen. 
0nly an insignificant trace of  antibody-antigen complex was found  in  the supernate 
of the serum antigen mixture used for removal of coprecipitating antibody. 
TABLE  IV 
Number of Participating Antibody-Antigen Systems in Alkali-Treated and 
Untreated Anti-CBPA 
Serum 
Non depleted ................................ 
Depleted of precipitating antibody (serum A)... 
Depleted  of  precipitating  and  coprecipitating 
antibody (serum B) ....................... 
Supernate from normal serum mixed with antigen 
and antiserum used for removal of coprecipitat- 
Lug antibody  .............................. 
Bandsprecipitated by diffusion of 4 per cent 
CBPA through mixtures of equal parts of agar 
and a 1:4 dilution of serum 
Untreated 
2.0 H* 
No band 
1.1 LM, 1.0 M 
1.2 LM, 1.0 M 
Alkali-treated 
2.0 MH 
2.1 M 
1.6  MH,  1.0  L, 
0.9 L 
1.2 LM, 1.0 M 
* Each figure indicates for one band the slope of the line obtained  by plotting mobility 
against the  square root  of  time.  Letters indicate the intensity of  each  band  (H--heavy; 
MHwmedium  to heavy;  M--medium;  LM--light  to medium;  Lwlight; LL--faint). The 
number of bands is indicated by the number of figure-letter entries. 
line egg albumin. The tubes were stored in the usual way and centrifuged. A new set of super- 
nares was collected and the N  content of the washed precipitates was determined (Table V). 
The supernates were treated with an excess of calibrated antiserum to determine the amount 
of remaining antigen (antigen removal capacity of the precipitates). Other portions of the 
superuates were used in gel diffusion tubes with a  4 per cent solution of CBPA as diffusing 
agent in order to determine the number of antibody-antigen systems remaining after pre- 
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Table V, column 2, shows that serum A, apparently depleted of precipitating 
antibody by 2 serial additions of antigen still contained a  trace of precipitating 
antibody, too small to give a band with the agar diffusion technique (Table IV). 
When serum A  was treated with alkali and antibody-antigen complex allowed 
to separate, the supernates precipitated large amounts of protein upon addition 
of varying quantities of CBPA (Table V, column 3).  Column 4  shows that in 
serum  B  depletion of precipitating and  coprecipitating antibody completely 
TABLE V 
Demonstration  of Material  Precipitable  with  CPBA  in  Antisera  Depleted  of Precipitating 
Antibody,  Coprecipitating  Antibody,  and  Soluble  Antibody-Antigen  Complex 
Serum A, anti-CPBA  depleted  of precipitating  antibody;  Serum  B, anti-CBPA  depleted  of precipitating 
and coprecipitatlng  antibody 
Residual  antibody  in super- 
hate (bands precipitated  by 
/~g.  N  p  recipitated/ml.  /zg.  residual  CBPA N in  ]  diffusion  of  4 per  cent 
undiluted  serum  supernate*  CBPA through mixture of 
equal  parts  of  supernate 
and agar)  Antigen N 
added/ml.  [ 
undiluted serum 
(1) 
4 ,ug. CBPA 
7  ~  ~ 
14  .... 
18  .... 
36  .... 
72  .... 
144  .... 
180  .... 
18  "  crystalline 
egg albumin 
Serum A  Serum B  Serum A 
(2)  (3)  (4)  (5)  (6)  t  (7) 
¢ 
0  78  0  0  105 
153  0 
281  0 
293  0 
349  0 
349  0 
349  0 
308 
0  0 
0 
0 
18 
24 
24 
12 
0 
Serum B  I  Serum A 
,~  -~  Untreated  ~A~ke~li~ 
(s)  (9)  I  (10)  [  (11) 
3  0  No band  1.9 M:~ 
6  I ....  INo band 
12  51  ....  I .... 
18  lO  I ....  [  .... 
4s  2s  I ....  I .... 
82  67  I ....  I .... 
175  150  [ ......... 
142 
142 
172 
228 
228 
222 
] 
0 
1 
5 
8 
30 
100 
200 
0 
2 
5 
15 
67 
150  I 
1751  I 
I 
! 
....  12.3 M 
* Equivalent to total supernate from 1 ml. undiluted serum. 
See footnote of Table IV. 
abolished the precipitating capacity of the serum with any amount of antigen 
tested. When serum B  was treated with alkali and antibody-antigen complex 
allowed to  separate,  again large  amounts  of precipitate were  obtained upon 
addition of CBPA to the supernates (column 5). With these data inhibition by 
excess  antigen  was  not  definite.  Other  experiments  indicate,  however,  that 
inhibition can be obtained with amounts of antigen varying between 3  and 25 
mg. nitrogen per ml. undiluted serum. None of the alkali-treated serum prepa- 
rations gave a precipitate upon addition of the non-specific material, crystalline 
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Determination  of antigen  remaining in the solution after separation  of the 
precipitates listed in columns 2  to 5  gave lower values for the alkali-treated 
than  the  untreated  serum  preparations  (columns  6  to  9),  showing  that  the 
precipitates obtained with antigen from the treated serum preparations removed 
antigen from solution. These data do not permit, however, a quantitative evalu- 
ation of the amount of antigen included in the precipitates since the amount of 
antigen recovered from untreated serum A (column 6) did not correspond very 
well to the amount of antigen originally added  (column 1). Better agreement 
between  these  two sets of values was obtained  with  the untreated  serum  B 
(column 8). 
Perhaps a soluble complex formed by a factor of the untreated serum A and added antigen 
interfered with subsequent complete precipitation of the antigen by an excess of calibrated 
antiserum. Employing radioiodinated antigen, such observations have previously been made 
by Robert Feinberg (14). For the preparation of serum B, depleted of coprecipitating as well 
as of precipitating antibody, more antigen was used than for the preparation of serum A. 
As shown below, this increased the amount of non-precipitating antibody-antigen complex 
(Table III) which may be capable of interference with precipitation of the antigen by sub- 
sequently added precipitating antiserum. Perhaps in the preparation of serum B (but not in 
the preparation of serum A) the serum factor which forms such an "interfering" complex 
may have been exhausted. Any further addition of antigen (as done by adding the amounts 
of antigen listed in column 1 to the non-alkali treated serum B) may have formed additional 
complexes of higher dissociabflity only which were unable to interfere with precipitation of 
antigen by subsequently added precipitating antiserum. This may be a reason for the better 
agreement of the amounts of antigen added (column 1) and the amounts of antigen detected 
(columu 8) in the untreated serum B. 
Table IV describes  the  bands  of precipitation occurring  upon  diffusion of 
CBPA into agar tubes containing the original non-depleted serum, sera A and 
B, untreated and alkali-treated. The non-depleted, untreated  serum gave one 
band  of precipitation  consistent  with  a  reaction  of  antibody  with  a  single 
component antigen.  The untreated  serum depleted  of precipitating antibody 
(serum A), failed to reveal a band of precipitation. However, when this serum 
was treated with alkali and antibody-antigen complex allowed to precipitated 
mixtures of the resulting supernate and agar revealed a band of precipitation 
upon diffusion of CBPA. This band had a similar mobility as the band obtained 
with the original non-depleted, untreated serum. When the non-depleted serum 
was treated with alkali and the antibody-antigen complex allowed to precipi- 
tate,  the  supernate,  containing  both  precipitating  antibody  and  the  factor 
precipitating with antigen after alkali treatment, showed only one band in gel 
diffusion. These data indicate that the material capable of precipitation with 
antigen  only  after  alkali  treatment  and  the  original  precipitating  antibody 
probably react  with  the  same  component  of  the  antigen  solution. 
Similar results were obtained with serum B  from which both precipitating 
and  coprecipitating  antibody  were  removed.  This  serum  formed  two  bands STERNBERGER, ]?EINBERG~ AND CLARKE  533 
with  CBPA. The supernate  of a  mixture  of normal  serum with the antigen 
and  antiserum  4 used for removal of coprecipitating  antibody gave 2 bands, 
whether alkali-treated or not. The 2 bands observed in the untreated serum B 
had a  similar  mobility as these 2 bands.  These bands appear to be derived, 
therefore, from the antiserum-antigen mixture used for absorption of coprecipi- 
tating antibody. When serum B was treated with alkali and antibody-antigen 
complex allowed to precipitate 3 bands were observed upon diffusion of CBPA. 
Two of these bands correspond to those of the absorption mixture but the third 
band had a mobility which is in fair agreement with that of the band of the 
original  non-depleted  serum.  Again  a  precipitin-like  material  which  reacted 
with the same antigenic determinant as the original precipitating antibody was 
apparently brought out by alkali treatment of the serum portion depleted of 
precipitating  and coprecipitating antibody. 
Gel diffusion was also employed to detect any antibody remaining  in solution 
after separation of the precipitates that formed in the alkali-treated and un- 
treated serum A upon addition of the amounts of antigen listed in Table V, 
column 1. When 4/zg.  CBPA nitrogen was added to the treated serum A the 
supernate was free of antigen (Table V, column 7), and still contained antibody 
(column 11). When 7 #g antigen were added the precipitating material revealed 
by alkali treatment was in equivalence,  the supernate showing neither antigen 
(column 7) nor antibody (column 11). With larger doses of antigen the reaction 
was in antigen excess. 
The preceding  analysis is consistent with an antiserum reacting with a single 
component antigen. 
Table III shows that depletion of precipitating  antibody from the original 
serum by addition  of antigen  in  the preparation  of serum A  increased  the 
amount  of  antibody-antigen  complex  precipitated  after  alkali  treatment. 
Removal of coprecipitating antibody with antiserum and antigen in the prepa- 
ration of serum B further increased the antibody-antigen complex. Apparently 
some of the antigen added combined with a  soluble factor in the serum and 
increased  the  amount of  antibody-antigen complex  precipitated  after alkali 
treatment. The increase  of complex precipitated from serum B as compared to 
serum A is paralleled by a decrease in the maximum amount of material pre- 
cipitable from the resulting  supernates upon  subsequent addition of antigen 
(Table V,  columns 3  and  5).  The  total  amount  of material  precipitable by 
antigen and disclosed by alkali treatment is reflected by the sum of the following 
two entities:  (a)  the  difference  between antibody-antigen  complex nitrogen 
precipitated from the alkali treated serum depleted of precipitating antibody 
and  the  treated  non-depleted  serum;  (b)  the maximum  amount  of nitrogen 
precipitable  upon  the  addition  of  antigen  to  the  supernate  obtained  after 
removal of the antibody-antigen complex  from the alkali-treated  serum de- 
4  This antiserum  alone produced with the aid of Freund's adjuvants gave 3 bands. 534  STUDIES  ON  NON-PRECIPITATING ANTIBODY.  I 
pleted of precipitating antibody. In the case of serum A this is (169-120)  -b 
349  =  398 #g. nitrogen per ml. and in the case of serum B, (253-120)  -b  228 
=  361 ~g. nitrogen per ml. This analysis is only qualitative since the amount 
of antigen incorporated in each of these precipitates is not accurately known. 
The loss of 37 #g. nitrogen per ml. of material precipitable by antigen from the 
alkali-treated serum B as compared to A may  be due to removal of coprecipitating 
antibody in serum B  (18  /~g. nitrogen per ml.)  or may reflect experimental 
error. 
The data of this experiment seem to indicate that in sera depleted of pre- 
cipitating antibody, there appears upon alkali treatment a material which pre- 
cipitates  with  specific  antigen but  not with non-specific protein.  Untreated 
depleted serum fails to form significant precipitates with specific antigen. The 
precipitates remove antigen from solution. The data suggest, therefore, that 
alkali treatment converts a non-precipitating factor to a precipitin-like material. 
Experiment 3.  Conversion  of a  Non-Precipitating Factor to a  Precipitin-Like 
Material in an Antiserum to an Impure Antigen.uln the preceding experiment 
a  non-precipitating factor combining wih antigen was demonstrated by first 
depleting  antiserum  of precipitating  antibody,  then  treating  the  serum  by 
alkali and allowing antibody-antigen complex to separate, and finally adding 
antigen to the supernate and estimating the amount of precipitate obtained. 
For this purpose it was necessary to remove the precipitating antibody com- 
pletely before alkali  treatment.  If precipitating  antibody would  have  been 
left in solution it would have been possible for such antibody to aggregate with 
non-specific material upon treatment, and this might have given a false increase 
in  the  amount  of  precipitate.  Complete  removal  of precipitating  antibody 
without giving rise to conditions of antigen excess is possible only in an anti- 
serum to a pure antigen composed of a single reactive component. If an anti- 
serum  contains antibody to  trace  impurities of an antigen a  large  excess of 
antigen, as shown by Vaughan and Kabat (12),  may be necessary to remove 
all  the  precipitating  antibody.  In  an  antiserum reacting  with several  com- 
ponents  of an  impure  antigen demonstration of non-precipitating  antibody 
has to depend, therefore, upon the increased antigen removal capacity of the 
serum after alkali treatment as compared to this property before treatment. 
A pool of serum obtained after intravenous injections of BP~,G was found 
to react with 4 components of antigen. The serum was divided into two por- 
tions, A and B. Serum A was again divided into two portions. The first portion 
of serum A  was reacted with varying quantities of BP'yG labelled with Im. 
The other portion of serum A was treated by alkali, antibody-antigen complex 
was allowed to separate, and the supernate was reacted with similar quantities 
of BP'yG labelled with I  TM. The radioactivity precipitated from both the treated 
and  untreated  sera  was  compared  and  non-precipitating  antibody  was  ex- STERNBERGER~  I~EINBERG~ AND  CLARKE  535 
pressed by any increase in radioactivity  precipitated from the treated serum 
as  compared with untreated  serum. 
To serum B a small amount of antigen was added to deplete it of part of its 
precipitating  antibody.  Alkali-treated  and  untreated  portions  of  serum  B 
(after  removal  of  antibody-antigen  complex from the  treated  portion)  were 
then reacted with radioiodine labelled BPTG as in the case of serum A. 
Serum from 4  rabbits was obtained on the 14th day after a  single intravenous injection 
and also 14 days after a second biweekly intravenous injection of BPTG in the amount of 0.1 
mg./kg, body weight.  The pooled serum was found to precipitate 4  bands in gel diffusion 
,,4-' 
c] 
,4.J 
°~ 
.L2- 
o 
L 
c,. 
>,,, 
> 
4-; 
U 
o 
0 
-0 
o 
L. 
I00" 
80- 
00- 
40 
20 
.A 
un4:reoted 
an~i-BP-~G 
al kali-~craated 
an'ci-BPTG 
i5.8  32.6 
i  I  sl  i  I  i  i 
J2.5  31.8  64.7  163  326  680 
~.I  '3'- BP,..  r  G nitrogen odded 
Fro. 3.  Precipitation of radioiodinated BPyG by alkali-treated and untreated anti-BPTG. 
tests with 4 per cent BPyG. The serum was divided into two portions, A and B. Serum A was 
inactivated at 56  ° for 30 minutes. Serum B  was mixed with 9.7 #g. BPTG nitrogen per ml. 
of serum (this amount of antigen removed only a fraction of the total precipitating antibody 
and did not leave antigen in the supernate). The mixture was incubated at 37°C. for 2 hours, 
left at I°C. for II days and the supernate was obtained after centrifugation at I000 g at I°C. 
for 40 minutes. 
Both serum A and the supernate from serum B were divided into two portions. One of each 
2 portions was diluted to 4 volumes with respect to the original serum. The other portions 
of both sera A and B were treated by alkali (resulting in a 4-fold dilution with respect to the 
original serum) and left to precipitate. Following centrifugation of these four serum portions, 
4 ml. samples of each of the resulting supernates were added in duplicates to 1.0 ml. portions 
of merthiolated saline containing varying amounts of radioiodinated BP'yG. The mixtures 
were left at I°C. for 11 days, centrifuged at i000 g at I°C. for 20 minutes, the precipitates 536  STUDIES  ON  NON-PRECIPITATING  ANTIBODY.  I 
were washed 3  times with 6.0 ml. portions of 0.16  N sodium chloride solution at  I°C., and 
their radioactivity was determined. Alkali-treated anti-alternaria serum and purified Alt~f~,da 
antigen (15) were also mixed with radioiodinated BP~G in order to obtain data on non-specific 
absorption of the radioiodinated antigen. 
Fig. 3 shows that more radioactivity was removed by the alkali treated than 
the untreated serum A,  indicating that  the  treatment disclosed a  material 
which precipitated antigen. The untreated serum precipitated only 68 per cent 
of 12.5 #g. antigen nitrogen added, while treated serum gave complete precipita- 
tion. The supernate from the untreated serum to which 12.5 pg. antigen nitro- 
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depleted of part of its precipitating antibody. 
gen was added was free of antigen precipitable  with specific antiserum. When 
increasing amounts of antigen were added, a lesser proportion of the antigen 
was precipitated by the treated serum.  With any amount of antigen except 
31.8 #g. nitrogen,  more antigen was precipitated by the treated than by the 
untreated serum. 
When the serum was depleted of a part of its precipitating antibodies (serum 
B), the difference in the proportion  of antigen removed from the alkali-treated 
and untreated serum  became  accentuated (Fig.  4).  This indicates that  the 
depletion  removed  precipitating antibody from the system without propor- 
tionally diminishing  the antigen removal  capacity of the factor disclosed by 
alkali treatment. STERNBEEGER, FEINBERG, AND CLARKE  537 
No  significant amount  of radioactivity was  precipitated by alkali-treated 
anti-Alternaria  serum, purified Alternaria  antigen and radioiodinated BPTG, 
indicating that non-specific absorption of antigen did not occur. 
The experiment demonstrates that there exists in the alkali-treated serum a 
material which precipitates antigen specifically and which is not disclosed in 
the untreated serum. This suggests that a non-precipitating serum factor ap- 
parently is converted to a precipitin-like material, that this can be accomplished 
in the presence of precipitating antibody and that it holds true for sera reacting 
with multiple components of antigen as well as for single component antibody- 
antigen  systems. 
Experiment  4. Increase of Non-Precipitating  Antibody-Antigen  Complex upon 
Addition  of  Antigen  to  Antiserum  to  Powdered (Non-Crystalline)  BPA  and 
Freund's Adjuvants Depleted of Part of Its Precipitating Antibody.--The antisera 
used for the preceding experiments were produced by infrequent intravenous 
injections of relatively large quantities of protein. With this method appreciable 
amounts of material precipitable with antigen after alkali treatment are pro- 
duced but no excessive quantities of precipitating antibody form. The present 
experiment was undertaken to learn whether formation of large amounts of 
precipitating antibody such as occurs in immunization with Freund's complete 
adjuvants (2, 3) parallels or precludes the appearance of material precipitable 
with antigen after alkali treatment. 
By serial additions of small amounts of antigen, antiserum to powdered BPA 
was  depleted  of most  of its  precipitating  antibody.  This  comprised  all  the 
antibody to one of the 3 antigen components of CBPA with which the serum 
reacted. The partially depleted serum was then mixed with varying additional 
quantities  of the  antigen and  the  resulting precipitates  were removed. The 
ensuing  supernates  were  treated  with  alkali  and  antibody-antigen complex 
was allowed to separate. The amounts of antibody-antigen complex precipitated 
after  treatment  by  these  supernates  were  compared with  the  complex pre- 
cipitated by depleted serum to which no additional antigen was added.  The 
solutions  remaining  after  separation  of  antibody-antigen  complex from  the 
alkali treated supernates and untreated controls were tested for excess antigen 
and  antibody. The number of antigen components capable  of reacting with 
these solutions was  inferred from gel diffusion tubes. 
A pool of serum from rabbits immunized with powdered BPA and Freund's adjuvants was 
obtained. Upon diffusion of 4 per cent CBPA into serum agar mixtures 3 bands resulted. 
Apparently there are small amounts of impurities in the CBPA that can be detected if a less 
purified antigen is used for immunization, particularly  when in Freund's complete adju- 
vants (2, 3). 
The serum was depleted of 712 #g. precipitating antibody nitrogen per ml. by four suc- 
cessive additions each of 13/~g. CBPA nitrogen per ml. of serum. After each of the first three 
additions the serum was incubated at 37°C. for 30 minutes and centrifuged  at 1000 g at I°C. 
for 20 minutes. After the fourth addition it was left at 37°C. for 2 hours and at 1°C. for 7 days 538  STUDIES  ON  NON-PRECIPITATING ANTIBODY.  I 
and centrifuged at I000 g at l°C. for 40 minutes. As a result of this procedure the serum was 
free of antibody in qualitative tests with 4 pg. but not with 40 pg. CBPA nitrogen per ml. 
undiluted serum, indicating that apparently an antibody to a  trace impurity of CBPA was 
still left in the serum (12).  Tests for free antigen were negative. 
Portions of depleted serum were mixed with different quantities of CBPA or with merthio- 
lated saline.  They were incubated at 37 ° for 2 hours, left at 1°C. for 7 days, and centrifuged 
at 1000 g at 1  ° for 20 minutes. Table VI, column 2, gives the nitrogen determinations of the 
washed precipitates representing residual precipitating antibody in the depleted serum. Each 
of the resulting supemates was divided into two portions. One of these portions was treated 
TABLE VI 
Precipitates Formed in Alkali-Treated Supernates from Mixtures of Varying Amounts of CBPA 
with Antiserum to Powdered  BPA and Freund's Adjuvants Depleted of Part of 
Its Precipitatin  Antibody 
(t)  (2)  (3) 
/~g..N. 
prectpl- 
tated 
per ml. 
undiluted 
sernnt 
pg. N 
per  mL 
undiluted 
serum 
spontane- 
ously pre- 
cipitated 
from 
untreated 
super- 
nates of 2 
13 
Trace 
11 
Trace 
0 
0 
0 
C~A 
added 
l.,~rl. 
tepleted 
serlnn 
(1.0 ml. 
tin- 
diluted 
serum) 
II 
21 
43 
86 
108 
216 
432 
11 
17 
11 
10 
19 
Trace 
15 
(4) I  (s) 
Tests on su~eraates 
from precipitates in 
column 3 
Bands precipitated 
Ex-  by diffusion of 
cess  4 per cent CPBA 
anti-  through a mixture 
of equal parts of 
gen  supernates and 
agar 
--  0.TM,  0.6 MH~: 
+  0.7 M,  0.6 MH 
+  0.7 M,  0.6 H 
+  0.7 MH, 0.6H 
+  0.7 MH, 0.5 H 
+  0.7 MH, 0.5 H 
+  0.8 MH, 0.6H 
+  0.8 MH, 0.6 H 
+  0.8 MI-I, 0.6 H 
+  0.8 MH, 0.6 H 
(6)  (7) 
Increase 
~g. N/mL  due to 
undiluted  addition of 
serum  antigen in 
spontane-  /~g.  N/ml. 
ously pre-  undiluted 
cipitated  serum spon- 
from  taneously 
alkali-  precipitated 
treated  from alkali- 
supernates  treated 
of 2*  supernates 
of 2 
49 
78  29 
112  63 
143  94 
117  68 
122  73 
189  140 
118  69 
196  147 
180  131 
(s)  [  (9) 
Tests on supemates 
from precipRates in 
column 6 
Bands preclpi- 
Ex-  tated by di~usio~ 
of 4 per cent 
cess  CBPA through a 
anti-  mixture of equal 
sen  parts of super- 
hates and agar 
--  1.8  L,  0.7  M, 
0.6 Ht 
--  1.6  L,  0.8  M, 
0.6H 
+  2.4 LL,  0.8  MH 
0.6H 
+  0.8 MH, 0.6 H 
+  0.8 MI:I, 0.6 H 
+  0.8 MH, 0.6H 
+  O.8 MH, O.6 H 
+  0.8 MH, 0.6H 
+  0.8 MH, 0.6 H 
+  0.8 MH, 0.6 H 
* Corrected for spontaneous  preclpitates, if any, occurnng in untreated supernates (column 3). 
See footnote of Table IV. 
with alkali and made up with merthiolated saline to 4 volumes with regard to the original 
serum. The other (control) portion was not treated but was diluted similarly with merthio- 
hted saline. 4 ml. triplicate samples of each supernate were left at 1°C. for 11 days. The tubes 
were then centrifuged at 1000 g at 1°C. for 20 minutes, a set of new supernates was colleeted 
and the nitrogen content of the washed precipitates determined. The new supernates were 
tested by gel diffusion  for excess of material reacting with antigen. They were also examined 
for excess antigen by addition of equal volumes of anti-CBPA produced with Freund's ad- 
juvants. The tubes were read after incubation at 37  ° for i hour and storage at 1°C. for 1 day. 
Table VI, column 2 gives the amounts of precipitate obtained by the addition 
of varying quantities of antigen to serum  depleted of most of its precipitating 
antibody.  Column 3  shows that most of the supernates  from these precipitates STERNBERGER, FEINBERG, AND CLARKE  539 
when simply diluted and stored at I°C. for 11 days, but not treated with alkali, 
failed to form additional precipitates.  The small amount of precipitate observed 
in  some  of  the  samples  apparently was  due  to incomplete  precipitation of 
precipitating antibody after addition of antigen to the partially depleted serum. 
However, when the supernates were treated with alkali large amounts of precipi- 
tate formed (column 6). The amount of these precipitates exceeded the amount 
of antibody-antigen complex in the depleted serum,  i.e.  the amount of pre- 
cipitate obtained from the alkali-treated sample of depleted serum to which, 
instead of antigen, merthiolated saline was added. This increase  is shown in 
column 7.  These results are  consistent with the assumption that a  soluble 
complex was formed by addition of antigen to the serum depleted of most of 
its precipitating antibody. This complex apparently precipitated upon alkali 
treatment  and  resulted  in  an  increase  of  antibody-antigen complex  when 
compared  with the amount of complex precipitated from the depleted serum 
to which no antigen was added. No regular pattern was observed, however, in 
this increase of complex when increasing  amounts of antigen were used. This 
may be due to the presence of multiple antibody-antigen systems in the serum. 
Such  irregular  increase  of  precipitation from  alkali-treated serum with in- 
creasing  amounts of antigen was not observed  in sera  obtained after intra- 
venous injections of CBPA that reacted with a single antigen component only. 
Tests on the supernates remaining after separation of antibody-antigen com- 
plex from the alkali-treated samples are given in columns 8 and 9 and tests 
on the corresponding untreated controls in columns in columns 4 and 5. The 
supernate obtained after alkali treatment from depleted serum admixed with 
2/~g.  CBPA nitrogen per ml. original serum was free of antigen (column 8). 
Antigen  was  left in  the  supernate  of  the  corresponding  untreated  sample 
(column  4).  Hence the  predpitate  obtained  after  treatment  incorporated 
antigen. (The alkali treatment itself does not destroy the antigen in mixtures 
of CBPA and normal serum.)  Gel diffusion revealed 2 bands in the supernates 
from the untreated samples  (column  5)  (the original unabsorbed serum  had 
3 bands). These 2 bands did not disappear from the supernates with any of the 
amounts of antigen used, showing that they are due to a trace impurity of the 
antigen too small to neutralize all the antibody with any of these antigen doses 
(12). Two bands of the same mobility appeared  in the supernates from the 
alkali-treated samples  (column 9). However,  a third band was also apparent 
in the supernate from the sample to which no antigen was added and in the 
supernates from the samples admixed with up to 4/~g. antigen nitrogen per ml. 
original serum. Since the original serum precipitated 3 bands, and the depleted 
untreated serum 2 bands, reappearance  of a third band after alkali treatment 
of the depleted serum is consistent with the existence in the latter of a material 
reacting with the main component of antigen without forming  precipitates 
but precipitating with antigen after alkali treatment. In the sample admixed 540  STUDIES ON NON-PI%ECIPITATING ANTIBODY.  I 
with 4/~g. antigen nitrogen per ml.  of original  serum, the supernate obtained 
after alkali  treatment contained both antigen and free antibody, reacting with 
each of the 3 antigen components. This may indicate a possible coexistence  of 
antigen and the material disclosed by alkali treatment. 
GENERAL  DISCUSSION 
Antisera to which no antigen is added usually form precipitates upon alkali 
treatment.  These precipitates are derived from circulating  non-precipitating 
antibody-antigen complex (1). Experiments 1 and 4 of the present work show 
that  in  antisera  depleted of precipitating  antibody the  addition  of antigen 
increases the amount of these precipitates obtained after alkali treatment. This 
increase may be due to one of two causes. Either the antibody-antigen complex 
contained  in  the serum  is by itself capable of binding  antigen  beyond the 
amount  it already contains,  or  there  may be present  in  the  serum another 
soluble factor which precipitates with antigen  after alkali  treatment.  In Ex- 
periments 2 and 3 antibody-antigen complex was allowed first to separate from 
alkali-treated sera which had been depleted in varying degrees of precipitating 
antibody, and antigen was added only later. This resulted in further precipita- 
tion,  while  untreated  sera  did  not  produce  precipitates.  The  material 
in alkali-treated serum precipitable with antigen is, therefore, distinct from the 
antibody-antigen complex  originally  present.  It fails  to precipitate from un- 
treated  serum.  After  treatment  it  resembles  precipitating  antibody  by its 
capacity to precipitate specifically  with antigen but not with saline  nor with 
non-specific protein, and by its capacity to bind antigen during this precipita- 
tion. Gel diffusion tests showed that the material revealed by alkali treatment 
of serum which had been depleted of precipitating antibody reacted with the 
same  component  of antigen  as  the  precipitating  antibody of non-depleted, 
untreated serum.  These findings  support the conclusion  that the alkali treat- 
ment converts a non-precipitable factor to a precipitin-like  material. 
This precipitin-like  material differs from precipitating antibody in that maxi- 
mal precipitation occurs in the antigen excess zone and that apparently higher 
concentrations of antigen are needed for inhibition.  In the region of moderate 
antigen excess close to the equivalence zone considerable  amounts of the ma- 
terial may apparently coexist with antigen in the supernates. This may be due 
to a greater dissociability of the antigen from the material disclosed by alkali 
treatment than from precipitating antibody in untreated serum and resembles 
the behavior of precipitating  antibody with a  cross-reactlng  antigen  such as 
described by Pennel  and  Huddelson (16). 
The nature of the alteration that causes appearance of precipitin-like  material 
on alkali treatment is not understood. Of course, without change  in structure 
the precipitin like material would never form. The precipitates obtained reflect, 
therefore, merely a  means of estimating  the presence of such material.  They STEENBEEGER~ FEINBERG, AND  CLARKE  541 
do not represent the unaltered non-precipitating material that may have been 
originally found in the serum. Their behavior after dissociation  does not permit 
definite conclusions  about the nature of their mother substance in the native 
serum.  However, the cause of precipitation  is not denaturation.  If immune 
sera are treated under conditions favoring denaturation, such as pH 12.6 for 6 
minutes at room temperature,  no precipitates form upon neutralization  and 
storage at 1°C. showing  that denaturation destroys rather than produces the 
capacity of forming precipitates. 
Aggregation  of  precipitating  antibody with  non-specific  material  such  as 
occurs in treatment of serum with guanidine (17) or heat (18) could be a factor 
in  increasing  the  amount  of precipitate  obtained  with  antigen  after  alkali 
treatment.  In order to exclude  this possibility, care was taken in the present 
experiments to deplete precipitating  antibody from serum before treatment. 
After depletion no significant  precipitation occurred with antigen in untreated 
sera reacting with a single component of antigen. Any precipitating antibody 
that could nevertheless have remained in solution in untreated depleted serum 
depends  on  the  solubility  of  antibody-antigen  precipitates,  which  is  2  /~g. 
nitrogen per ml. as determined by the effect of volume on precipitation at I°C. 
for 11 days (19). Since5 ml. volumes (4 ml. of diluted serum and 1 ml. of antigen) 
were employed for each precipitation,  not more than  10 ~g.  nitrogen of pre- 
cipitating antibody in combination with antigen could have remained in solution 
in equivalence or antibody excess of untreated serum.  After alkali treatment 
up to 306 #g. nitrogen were precipitated specifically from serum mixed before 
treatment  with antigen  in antibody excess.  If aggregation  would have been 
responsible for  this  phenomenon,  antibody would have  aggregated  with  30 
times its weight of protein.  It is unlikely that  specificity  would have been 
retained under conditions of so extensive aggregation  since  it  is known that 
extensive aggregation  of antibody in the presence of serum proteins abolishes 
or decreases its specific precipitability (17,  18).  Also,  serum devoid of  non- 
precipitating  specific factors but containing  traces of precipitating  antibody 
and  antigen  retained  in  solution by nature  of their  solubility remains  clear 
after alkali treatment, just as normal serum does (19). The fact that immune 
sera, depleted of precipitating  antibody by the addition of antigen,  show an 
increase  of  antibody-antigen  complex  precipitating  after  dissociation  must, 
therefore,  be attributed  to  other  causes  than  extensive aggregation  of any 
precipitating antibody and antigen that remained in solution after depletion. 
Furthermore,  in some experiments antiserum was depleted of precipitating 
antibody, treated with alkali,  and  antibody-antigen complex was allowed to 
precipitate. The remaining  supernates contained material precipitating specifi- 
cally with antigen.  If alkali treatment had produced preclpiation of a residue 
of traces of precipitating antibody and antigen which had remained in solution 
in the depleted serum, this material would have separated along with antibody- 542  STUDIES  ON  NON-PRECIPITATING  ANTIBODY.  I 
antigen complex, and not upon the subsequent addition of antigen to the re- 
sulting supernates. 
Finally unpublished  experiments  have  shown  that  isolated  precipitating 
antibody will aggregate  with 76 to 150 per cent its weight when treated with 
alkali in the presence of normal serum, lesser aggregation occurring in antibody 
excess than in antigen excess. The amount of antibody-antigen complex pre- 
cipitating after treatment of sera  which  had been  depleted  of precipitating 
antibody in the present experiments  exceeded by far the amount expected if 
the complex were derived from any traces of precipitating antibody and antigen 
that could have remained in solution in untreated serum. When precipitating 
antibody and radioiodinated antigen in antigen excess and in equivalence are 
treated with alkali in the presence of normal serum, neutralized, and allowed 
to reprecipitate,  the same amount of radioiodineolabelled antigen will be lost 
in the combined supernates and washings of treated as of untreated precipitates. 
The  increased  amounts of antigen precipitated by treated as  compared  to 
untreated sera in the present experiments are, therefore, not due to impairment 
of solubility of any precipitates derived from precipitating antibody and anti- 
gen, but result from the effect of alkali treatment on a factor other than pre- 
cipitating antibody. 
The alkali treatment revealed  material precipitable  with antigen in  sera 
depleted  of precipitating antibody by single additions of antigen in antigen 
excess (Experiment 1) or by repeated additions of antigen in antibody excess 
(Experiments 2 and 4). It does not depend, therefore, on the ratio of the antigen 
employed  and  the precipitating antibody removed during depletion of  the 
serum. This is further indication that the material disclosed by alkali treatment 
is not derived from solubilization of any precipitates of precipitating antibody 
and  antigen. 
All  these  considerations  support the conclusion  that the alkali treatment 
discloses a material precipitating with antigen which before treatment has been 
in the state of a non-precipitating entity. The precipitates  obtained after treat- 
ment are  not derived  from any residual  precipitating antibody retained in 
solution before treatment. 
What was the original nature of the precipitin-like material before the inter- 
ference of the alkali treatment? Does the treatment complete the production of 
a precipitating antibody from a percursor or does it convert a non-precipitating 
antibody of serum to a precipitin-like  material? When precipitating antibody 
is removed from serum by small serial additions of antigen in antibody excess 
and the depleted serum is treated with alkali, the amount of antibody-antigen 
complex precipitated exceeds that of the original serum (Table III). Apparently 
some of the antigen added is bound by a factor in the untreated serum and pre- 
vented from precipitation.  This would indicate  that the material disclosed by 
alkali  treatment is derived  from a  non-precipitating  antibody preformed in 
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the treatment.  It is d  interest that none of the antigen seemingly bound by 
non-precipitating  antibody  during  absorption  of  precipitating  antibody  by 
small amounts d  antigen can be detected by addition of precipitating antibody. 
Apparently the dissociability d  some of the complexes between non-precipitat- 
ing antibody and antigen formed in untreated serum is so low that su~cient 
free antigen is not available for precipitation  with precipitating  antibody. A 
more direct demonstration of strong binding of antigen by a non-precipitating 
factor in serum has recently been obtained by Robert Feinberg (14).  This is 
also suggested from some of the data d  Fig. 3.  Apparently it is this strong 
antigen binding factor which is, possibly along  with other soluble factors of 
lesser  binding  strength,  converted by the alkali  treatment  to precipitin-like 
material.  It appears feasible  that upon addition of small  amounts of antigen 
to antiserum complexes d  low dissociabillty form first,  while other complexes 
d  higher  dissociability are only revealed when an excess of antigen  is used. 
Considerable  dissociation  of  some  complexes  under  conditions  d  antigen 
excess has already been indicated in the preceding discussion by the coexistence 
of antigen and antibody in some of the supernates obtained from alkali-treated 
serum and  excess  antigen. 
Among the possibilities  for the mechanism by which the alkali  treatment 
converts  non-precipitating  antibody to precipitin-llke  material,  perhaps  the 
following two may deserve consideration. 
It is feasible that some antibody is non-precipitating because it is complexed 
with a  non-spec~c inhibitor  that keeps it in solution.  It is known that  the 
alkali treatment effects dissociation  of various complexes, such as precipitating 
antibody and antigen (20), complexes of complement with antibody and antigen 
(I) and thrombin-antithrombin complex  (21). Perhaps the treatment results in 
a  similar  separation  of non-precipitating  antibody from  a  hypothetical  in- 
hibitor.  It may even cause destruction of such an inhibitor,  just as it effects 
destruction of complement concurrent with dissociation  of antibody-antigen- 
complement  complex. 
Another possibility  may be a masked combining site of non-precipitating anti- 
body. Perhaps the alkali treatment permits just that degree of unfolding neces- 
sary to expose such a  combining  site. 
The data of this paper neither suggest nor preclude a similarity of the non- 
precipitating  antibody described by Heidelberger and coworkers (13)  (copre- 
cipitating  antibody)  and  at  least  some  of  the  non-precipitating  antibodies 
disclosed by alkali treatment. Because of the large amounts of non-precipitating 
antibody remaining after removal of relatively small quantities of coprecipitat- 
ing antibody (tested for completeness of absorption), it is not possible to ascer- 
tain  whether  this  removal  decreased the  total  amount  of non-precipitating 
antibody revealed by alkali treatment. 
The formation of non-precipitating antibody in immunization explains  the 
regular appearance d  large amounts of circulating antibody-antigen complex. 544  STUDIES  ON  NON-PP~ECIPITATING  ANTIBODY.  I 
Apparently during immunization most of the antigen is removed by precipitat- 
ing antibody and metabolized subsequently. Yet some of the antigen or material 
reacting  like  antigen  may persist  in  circulation  in  combination with  non- 
precipitating antibody and form soluble antibody-antigen complex (I). 
SUMMARY 
Brief exposure of serum to alkali in the cold seems to convert non-precipitat- 
ing antibody to a precipitin-like material. This was disclosed by the following 
lines of evidence. 
I. Immune sera, after addition of antigen and removal of the ensuing precipi- 
tates, yielded after alkali treatment more antibody-antigen complex than did 
aera to which no antigen was added. 
2. When immune sera were depleted of precipitating antibody, treated by 
alkali, and antibody-antigen complex was allowed to precipitate,  the resulting 
supernates formed additional precipitates upon admixture of specific antigen. 
No precipitation occurred upon addition of non-specific protein to the treated 
supernates or the addition of specific antigen to depleted sera not treated by 
alkali. 
3. Alkali-treated immune sera precipitated more antigen than untreated sera. 
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